This paper reports a wirelessly powered ionic polymer-metal composite (IPMC) soft actuator operated by external radio frequency (RF) magnetic fields for targeted drug delivery. A 183 μm thick IPMC cantilever valve was fitted with an embedded LC resonant circuit to wirelessly control the actuator when the field frequency is tuned to its resonant frequency of approximately 25 MHz. Experimental characterization of the fabricated actuator showed a cumulative cantilever deflection of 160 μm for three repeated RF ON-OFF cycles at 0.6 W input power. The device was loaded with a dye solution and immersed in DI water to demonstrate wireless drug release. The qualitative result shows the successful release of the dye solution from the device reservoir. The release rate can be controlled by tuning the RF input power. We achieved a maximum average release rate of ∼0.1 μl s −1 . We further conducted an in vitro study with human tumor cells (HeLa) to demonstrate the proof of concept of the developed device. The experiments show promising results towards the intended drug delivery application.
Introduction
Recent advances in micromachining and 3D nanoprinting technology 1, 2 have led to extensive research and development activities of wirelessly controllable actuators. These actuators are particularly suitable for implantable drug delivery devices, which allow drugs to be provided precisely at a specific site. These devices allow automated drug release at an efficacious location to maximize the effectiveness of drug therapies such as epilepsy treatment, 3 chronic diseases, 4,5 osteoporosis treatment, 6 cardiac resuscitation, 7 cancer radiation reduction 8 and diabetic retinopathy. 9 Early approaches of wireless drug delivery use actuators [10] [11] [12] that require additional components, control circuitry and batteries to trigger drug release. However, this approach makes the device bulky and more invasive. Moreover, a limited battery life is detrimental to the patient's health. Different types of wireless thermal microactuators for drug delivery applications have been reported, including shape memory polymer (SMP), 13 hydrogel 14 and thermopneumatic actuators. 15 Although a drug can be precisely delivered to the targeted cells, the thermal actua-tors might cause tissue damage and therefore are not well suited for implantable devices. In addition, changes in the in vivo environment might deteriorate the actuator performance. Low-voltage actuation may be a feasible approach for implantable devices to overcome the heating problem.
An ionic polymer metal composite (IPMC) actuator is a promising candidate that can be operated under a relatively low voltage and without induced heat. The IPMC actuator is an electroactive polymer (EAP) that eliminates the need for a complex fabrication process. The actuator consists of a thin ion exchange polymer membrane sandwiched between two metal electrodes. This actuator provides a fast response and can be easily miniaturized. 16 To broaden the actuator's mobility, a wireless powered IPMC has been extensively investigated. Lee et al. reported a 9 GHz microwave powered IPMC actuator using a microstrip patch antenna patterned on the surface of the IPMC. 17 This approach, despite eliminating battery involvement, is sensitive to environmental changes, i.e. temperature and humidity. 18 Additional circuitry such as a band pass filter is required to eliminate the external interference. Low-frequency wireless radio frequency (RF) magnetic field power transfer offers the greatest potential to power the IPMC as it has lower power consumption and is relatively stable. One of such applications with a wireless power supply was reported by K. Abdelnour et al. with a magnetic coupled inductor-capacitor (LC) receiver coil for underwater robotic microswimmers. 19 The power was transferred wirelessly to the LC coaxial coil, when its frequency was tuned to the same resonant frequency as the external power source. However, the device tends to have a larger footprint which has limited its practicability in packaging.
There have been some development efforts using an IPMC soft actuator for controlled drug delivery. The biocompatible and soft muscle-like actuation makes this actuator well suited for wearable or implantable devices. 20 An active-pumping drug delivery device 21, 22 offers a high drug release rate and controlled pulsatile dosage. In these reports, the oscillatory movement of the IPMC based membrane creates a low pressure to draw the fluid into the pumping chamber and a high pressure to force the fluid out to the pump outlet. This drug release was constrained by the stroke formation of the IPMC membrane and prone to device failure. Moreover, the design poses the risk of incomplete drug release from the reservoir. Recently, Mousavi et al. reported a remotely controlled IPMC capping layer for triggering the opening of an orifice to induce drug release through diffusion. 23 Although the drug release can be triggered wirelessly, the diffusive release profile limits the precise dosage control. In addition, the use of silicon as a device material required a complex fabrication and LC integration process. To the best of our knowledge, only this work reported the application of the IPMC for drug delivery in a wireless manner; there is no experimental study on the behavior of the cells with the released drug.
The present paper reports a potential implantable drug delivery device using a soft cantilever valve that is made of an ionic polymer-metal composite (IPMC) actuator with an integrated planar LC receiver circuit. Under an applied voltage, the developed cantilever valve is deflected to activate the drug release mechanism. This voltage is generated, when the external radio-frequency (RF) magnetic field matches the resonant frequency of the LC receiver circuit. Resonant coupling is chosen as the wireless powering scheme due to its robust performance. Advantages such as a long wireless transmission distance have been discussed in our previous work. 24 A systematic in vitro study demonstrates the reduction of HeLa cell viability through the release of the drug cisplatin from the fabricated prototype. These results demonstrated the proof of concept of our wirelessly activated soft IPMC cantilever valve for mobile, reliable and safe targeted drug delivery.
Device design and working principle
The design of the developed drug delivery device is depicted in Fig. 1(a and b) . The device body was made of biocompatible polydimethylsiloxane (PDMS). 25 It is designed to have overall dimensions of 15 × 25 × 6 mm 3 , including a drug reservoir with a maximum loading capacity of 520 μL. The wireless power transfer setup utilized a planar inductor-capacitor (LC) resonant circuit that serves as the wireless receiver to activate the IPMC cantilever and an external transmitter circuit. The LC receiver circuit consists of two rectangular-spiral coils as the resonator and load loops or source loops with integrated capacitor plates to form an LC tank, fabricated using printed circuit board technology. The inductances of the square loop pattern in both circuits are expressed by the modified Wheeler formula:
where ρ is the fill ratio, n is the number of turns, and K 1 and K 2 are the layout coefficients, respectively. The outer coil diameter is defined as d out and the inner diameter is defined as d in to calculate the average diameter, d avg = 0.5(d out + d in ). The resonant frequency of the LC tank of both circuits can be determined using the following equation:
The LC tank is coupled with a DC rectifier circuit, fabricated from a single-sided copper-clad polyimide (PI) film with 0.11 μm thickness. The LC receiver circuit is encapsulated at the bottom of the device body with a 0.1 mm thick PDMS layer. A square cavity is created at the pump body to accommodate a DC rectifier circuit with an integrated IPMC-based cantilever to function as a wireless valve to control the opening gap over the release orifice of the drug delivery device. The PDMS layer isolates the contact point between the cantilever and DC rectifier circuit, 26 preventing galvanic corrosion that may attack the electrodes while operating in an aqueous environment.
The operation of the device is controlled by wirelessly resonating the LC tank. The load loops induce an AC voltage through Faraday's law, 23 when it is exposed to the external magnetic field generated by the external transmitter circuit at its resonant frequency. The cantilever bends when the induced DC voltage from the DC rectifier circuit rises above a Lab on a Chip Paper critical value, due to the migration of mobile cations in the IPMC material to the cathode, as shown in Fig. 2(a) . This phenomenon creates pressure across the cantilever and bends it toward the anode. 27 This deflection opens the release orifice and creates pressure inside the reservoir to pump the drug out. The rate of drug release can be wirelessly controlled by manipulating the bending force through tuning the RF input power from the external transmitter. Increasing the RF power increases the bending displacement of the IPMC-based cantilever, leading to a larger pressure induced.
An analysis using COMSOL Multiphysics optimized the design dimension to provide sufficient displacement to move the valve away from the release orifice. The numerical model can predict the displacement and the temporal response of the IPMC-based cantilever valve. In the simulated model, the time-dependent transport of the cation in the IPMC-based cantilever is described using the Nernst-Planck equation.
where D is the diffusion constant, C is the cation concentration, μ is the mobility of cations, F is the Faraday constant, z is the charge number, and φ is the electric potential in the polymer. The cation velocity, u, can be expressed in terms of the solvent pressure gradient as:
where ΔV is the molar volume that quantifies the cation hydrophilicity and P is the solvent pressure. Fig. 2(b) shows the deflection of the cantilever as a function of the IPMC layer thickness under an applied DC voltage of 2 V. A single Nafion layer or a thickness of 183 μm results in the largest displacement. Increasing the thickness leads to the decrease of displacement due to the increasing stiffness of the cantilever. The inset in Fig. 2 (b) shows a maximum displacement of 0.11 mm, in good agreement with the experimental data.
Device fabrication and experiment setup
The construction of the drug delivery device followed three main steps, i.e., LC circuit fabrication, integration of the IPMC cantilever to the fabricated DC rectifier circuit and the fabrication of the pump body. Fig. 3 (a) shows the fabrication and integration processes for the fabrication of the drug delivery device. First, a double sided Cu-clad PI film (AP7156E, DuPont Pyralux polyimide film, USA) was patterned with two rectangular-spiral coils as the resonator and load loop and a capacitor plate via a dry film photolithography process. Next, both top and bottom sides of the LC receiver circuit undergo an etching process to remove the copper-clad layers. Vial contacts were etched at the PI film and sealed with silver conducting epoxy to connect the top and bottom copper sides of the PI film. Subsequently, a 0.11 mm thick DC rectifier circuit was fabricated using a similar method, with bonded power electronic components to form a class-D half wave rectifier circuit. The fabricated IPMC was cut into a T-shape to form an 8 mm long cantilever and bonded to the DC rectifier circuit. The electrical contact between the LC receiver circuit and DC rectifier circuit was achieved using silver conducting epoxy. Both circuits were coated with a polydimethylsiloxane (PDMS) layer (Sylgard 184, Dow Corning Corp, USA) (mixed at a ratio of 1 : 10) to make the surface electrically isolated and biocompatible. The IPMC-based cantilever valve was fabricated from a Nafion-117 film (Dupont, USA) of 183 μm thickness. The cantilever valve was cut into the desired dimension and shape prior to the blasting process to increase the surface area density 28 of the electrodes. After thorough cleaning in a mixture of sulphuric acid (H 2 SO 4 ) and hydrogen peroxide (H 2 O 2 ), the anode and cathode electrode pads were photolithographically patterned on the Nafion-117. The silver layer was then plated on both Nafion-117 surfaces (top and bottom) using a silver mirror electroless plating process by dipping the Nafion-117 into a complex solution of [AgĲNH 3 ) 2 ]OH, a mixture of 1.6 g sodium hydroxide, 1.2 g silver nitrate, 2 g ammonia solution (28%) and 120 g DI water for 5 minutes. The Nafion-117 film was later transferred to another solution (a mixture of 0.8 g glucose and 120 g DI water) for 5 minutes. The silver electrodes were formed in the following chemical reactions:
Later, the pump body was constructed by pouring the same PDMS solution to a 3-D printed mold (using B9Creator, USA) and cured at room temperature for 48 hours. Finally, the LC receiver circuit and DC rectifier circuit were bonded to the constructed pump body with a punched 1 mm release orifice. The LC receiver circuit is integrated as a wireless receiver into the IPMC-based cantilever using chemical deposition on the photolithographically patterned Nafion 117. The process forms different polarity electrode pads which are bonded to the DC rectifier. This technique allows for a small device footprint, in contrast to the previously reported bulky devices with external clamps as electrodes. 29 Fig. 3(b) shows the fabricated drug delivery device and a scanning electron microscopy (SEM) image of the fabricated IPMC-based cantilever with the silver electrode layer.
Demonstration of wirelessly controlled drug delivery was performed with the setup consisting of a square wave function generator (SFG-830, GW Instek, Taiwan) and a class-E power amplifier (output power of 0.65 W) that produced the magnetic field through the external transmitter connected to the amplifier. An oscilloscope (MDS1102CA, Matrix, China) was used to determine the electrical response of the LC receiver circuit. The setup also involved a laser displacement sensor (CD5-85, Optex, Japan) and a load cell (FX300i, A&D, Japan) to characterize the displacement and force of the cantilever valve, respectively. As a preliminary experiment, the fabricated LC receiver circuit was examined for its frequency dependency, separation distance and tilting alignment with an external transmitter. A wireless release test for visual demonstration was conducted by loading the device's reservoir with a food dye solution. The device was immersed in a beaker filled with DI water and then placed on top of the external transmitter. The device was then activated by radiating an RF field from the external transmitter (ESI, † Fig. S1 ). A similar setup was utilized to measure the quantitative release of drug concentration from the developed device to an aqueous environment. This time, the device reservoir was filled with a fluorescent solution (Sigma Aldrich, USA) and the liquid released was evaluated using a well-plate reader. An in vitro experiment was carried out by treating cervical tumor cells (HeLa cells) with cisplatin to demonstrate the proof of concept of the developed device for drug delivery application. For the cell culture experiment, both sterilized devices were loaded with cisplatin and submerged in Petri dishes filled with human cervix carcinoma cell line (HeLa) culture medium (mixture of 90% RPMI (Sigma Aldrich, USA) and 10% of fetal bovine serum (FBS) (Sigma Aldrich, USA)). The RF field was activated at one Petri dish whereas another Petri dish serves as a control sample (RF turned off). Both cell culture media were collected after 10 minutes of RF activation and transferred to 96 well-plates (Greiner 96 flat bottom transparent polystyrene, Sigma Aldrich, USA), which have HeLa cells cultured at a seeding density of 7000 cells per well. To examine the cell viability, 10% concentration of the MTT assay (Sigma Aldrich, USA) was added into the well with a volume of 10 μl and incubated in a 5% CO 2 incubator (HERAcell 150, Thermo (Heraeus), Germany) at 30°C for 1, 3 and 24 hours. All experiments were carried out in a biosafety cabinet (BIO II A, Telstar, Spain).
Results and discussion

Characterization of the fabricated LC receiver circuit
The drug delivery device is activated once it is exposed to the external electromagnetic field of the transmitter circuit when the field frequency matches the resonant frequency of the LC receiver circuit. As discussed in the previous section, the LC receiver circuit is encapsulated with a PDMS layer (∼0.02 mm thick) in the device package to comply with biocompatibility criteria. The impact of the PDMS layer on the resonant frequency of the LC receiver circuit was first examined. To determine the resonant frequency, the S 11 parameters of the two LC receiver circuits, with and without the PDMS layer, were measured using a vector network analyzer (VNA) (Rohde & Schwarz, Germany) via inductive coupling (ESI † Fig. S2 ) in air and in DI water. ESI † Fig. S3 shows that the thin PDMS layer does not create any significant change in the resonant frequency of the LC receiver circuit. Both samples exhibit an identical resonant frequency of approximately 25 MHz when measured in air and coupled with the DC rectifier circuit. To evaluate the effect of the working environment on the resonance (ESI, † Fig. S4 ), the LC receiver circuit covered with PDMS was tested in DI water, air and skin mimicking gels (with and without muscle and fat gel models). The resonant frequency in these media exhibits an almost identical response, while different values of the phase dip ( Fig. 4(a) ) were observed in water and air. The PDMS encapsulation of the LC receiver circuit isolates the LC coil from the operating media, 30 hence maintaining its inductance, in contrast to the device reported in ref. 31 with the resonant frequency shifted when changing from water to air. The difference value of the phase dip in water and air might be caused by the higher power absorption of water. 32 This test proved that the fabricated LC receiver circuit is well suited for implantation and may work in different media.
The output voltage of the LC receiver circuit also depends on the coupling mechanism of the transmitter circuit. The size of the transmitter coil is designed to have large dimensions to enhance the power transfer efficiency. Experiments were conducted to study the behavior of the output voltage of the LC receiver circuit (after being fed to the DC rectifier circuit) at different placement positions on the transmitter circuit, which has a receiver-transmitter separation distance of 1.5 cm. Fig. 4(b) shows that the LC receiver circuit achieves a large voltage response of approximately 2.9 V, when it is placed at the center of the transmitter circuit. The voltage decreases with increasing distance between the LC receiver circuit and the center of the transmitter circuit. Understanding the interaction between the transmitter and the LC receiver circuit is important for optimum power transfer. Thus, the maximum power transfer distance and the orientation of the LC receiver circuit were optimized. The result presented in Fig. 4(c) shows a gradual decrease of the DC voltage with increasing distance between the LC receiver circuit and the transmitter, due to less receiving power. This result suggests that the maximum separation distance between the transmitter circuit and LC receiver circuit is about 4.5 cm to produce an output voltage of approximately 1 Vdc, which is the minimum voltage to activate the IPMC-based cantilever. Fig. 4(d) shows the response of the LC receiver circuit at different alignment angles. The maximum voltage of approximately 3.1 Vdc was achieved with a parallel alignment (0 degrees from the transmitter). This trend is consistent with the fact that the maximum separation distance highly depends on the magnitude of the cutting flux. There is no cutting magnetic flux when the LC receiver circuit is placed perpendicular to the transmitter circuit.
Wireless test of the IPMC-based cantilever valve
The IPMC-based cantilever consists of an ion exchange sheet clamped with two silver electrode plates, behaving as a capacitor in a lumped mass model. 19 An impedance analysis was conducted to identify the capacitor behavior of the IPMCbased cantilever with a 10 Ω shunt resistor connected in series at multiple wireless DC step voltages of 1 V, 2 V and 3 V (maximum DC voltage from the DC rectifier circuit). The current induced at the IPMC-based cantilever was experimentally measured using a data acquisition module (Elvis board II, National Instruments, U.S). The current increases rapidly as each step voltage changes and slowly decreases to its steady state ( Fig. 5(a) ). This can be explained from the lumped mass model, where the current (corresponding to the motion of cations in the IPMC-based cantilever) stops flowing when it reaches equilibrium. The charge stored in the IPMC cantilever is proportional to the produced deflection, thus controlling the actuating behavior of the IPMC cantilever. Fig. 5(b) shows that the IPMC cantilever tip displacement and block force increase with increasing applied voltage, measured by immersing the developed device in a beaker filled with DI water which was placed on top of the transmitter circuit. The measurement shows a deflection of approximately 11 μm with a tip force of 0.1 mN at 1 Vdc induced voltage of the LC receiver circuit. Below 1 Vdc, the IPMC cantilever does not show any noticeable displacement as the low voltage is not able to initiate any cation motion. The tip force increases to 0.36 mN and 0.72 mN for 2 Vdc and 3 Vdc, respectively. It is worth noting that the displacement of the IPMC cantilever can be improved by depositing a stressor layer on the cantilever surface. 33, 34 Fig. 5(c) shows the response of the IPMC actuator activated in 3 sets of repeated RF ON-OFF cycles: 10 seconds RF ON and 10 seconds RF OFF with ∼3 Vdc output voltages. A cantilever displacement of 66 μm was measured at the 10th second of RF ON activation. The cantilever deflection, however, experiences a slight increase to 70 μm at the end of the RF OFF cycle. This behavior repeats until the end of the experiment with cumulative deflection values of 110 μm and 160 μm for the second and third cycle, respectively. To examine the increase of the IPMC displacement phenomenon at each RF OFF cycle, the voltage profile at the IPMC actuator is shown in Fig. 5(c) . The voltage slightly decreases after the 3rd second at the first RF ON cycle due to the capacitive effect ( Fig. 5(a) ).
On the other hand, the voltage decreases abruptly at the RF OFF cycle to approximately 2 Vdc. Fig. 5(d) shows the voltage time response of the rectifier circuit in one RF ON/ OFF cycle, which verifies the capacitive properties in the DC rectifier circuit. Fig. 5(b) shows that the IPMC actuator deflects at approximately 2 Vdc, therefore resulting in an increase in cumulative IPMC actuator displacement in the RF OFF cycle. The IPMC actuator remains at its final position if no voltage is applied across the membrane. As a preliminary test of wireless drug release for visual verification, a prototype with a reservoir filled with the dye solution was placed in a water-filled beaker and then activated with a RF field from an external transmitter circuit. The dye solution released from the reservoir to the surrounding water was clearly observed (ESI † Fig. S5) . These experiments qualitatively validated the device's functionality in a surrounding liquid at 0.4 W RF power. Table S1 in the ESI † compares the total power consumption for wireless drug delivery actuation with that of other devices reported in the literature. In comparison with thermally activated drug delivery devices, i.e. a shape memory polymer 31 (5 W) and a shape memory alloy 35 (1.1 W), our solution offers a significantly lower power consumption of 0.4 W and a higher flow rate of 3.6 μl min −1 . An electrolytic driven actuator 36 may operate with a lower power consumption of 4 mW. However, the flow rate output is relatively low (0.011 μL min −1 ). The consistency of drug release highly depends on the bubble generation rate, which has the risk of premature bubble collapse and recombination.
In vitro study
The quantitative release of drug concentration from the developed device to an aqueous environment was tested by measuring the fluorescent solution (Sigma Aldrich, USA) every 10 seconds using a well-plate reader. All the measurements were performed without agitation or forced flow. Prior to device activation, a leak test was performed with the device fully filled with fluorescein and immersed in DI water without turning on the RF power. Fig. 6(a) shows no distinct increase in intensity for the mentioned period, suggesting that there is negligible off-state leakage of fluorescein to the environment. The intensity increases in a cumulative and incremental manner at RF ON with a power of 0.4 W and 0.6 W at an average release rate of ∼0.06 μl s −1 and ∼0.1 μl s −1 , respectively. The results clearly demonstrate that tuned RF activation of the device is effective in performing fluorescein release using the wireless approach.
Practical applications require robustness and capability of the developed device to operate effectively in a tissue-like environment. We conducted an experiment by embedding the device in an agarose gel (Sigma Aldrich, USA). Agarose gel, known as a flexible substrate with physical properties similar to those of an extracellular matrix (ECM), 37, 38 has been widely used as a tissue-mimicking material. [39] [40] [41] The intensity of fluorescein, corresponding to the cumulative drug release (expressed in terms of total percentage) from the device's orifice, was measured using a fluorescence microscope (Olympus BX41, Tokyo, Japan). Fig. 6(b) presents the temporal response of fluorescein released from our device immersed in 0.2% agarose gel and DI water. The agarose content was chosen based on its comparable properties to collagen type I. 37 The device was then activated wirelessly with a RF power of 0.6 W. The concentration of fluorescein released in DI water increases over time. In the first 45 minutes, the fluorescein released in DI water was measured to be lower than that in agarose. We hypothesise that the released fluorescein present at the measurement location diffuses more quickly to the surrounding water than to the highly viscose agarose gel. The fluorescein in the reservoir is completely released in the surrounding DI water after 90 minutes. The percentage released in agarose gel was approximately 91%, indicating that the time required for full fluorescein release in agarose gel was longer than that in DI water. The test clearly showed welldefined and predictable responses of our device in different surrounding media.
To demonstrate the proof of concept of wirelessly activated drug delivery, an in vitro experiment was carried out by treating cervical tumor cells (HeLa Cells) with cisplatin. Cisplatin is a chemotherapeutic drug for the treatment of cervical cancer. [42] [43] [44] Fig. 6(c) illustrates the cell viability assay of the tumor cells with the drug released from the developed prototype immersed in fetal bovine serum with RF turned on for 10 minutes. The released drug solutions were collected 10 minutes after releasing the drug and transferred to 96-well plates. The results indicate that the viability of the HeLa cells decreases significantly 1 to 3 hours after the wirelessly triggered release, followed by gradual reduction to ∼30% cell viability at 24 hours. Our developed prototype does not show any drug release at RF OFF. This control study proves that the death of HeLa cells is not associated with any passive leakage or device material, but indeed by wirelessly controlled drug release. Fig. 6(d) and (e) present the HeLa cell morphologies at RF turned off (control) and RF turned on for 24 hour incubation periods, respectively. Healthy tumor cells are observed to form a cohesive cluster with a well-shaped and smooth surface for RF turned off. The tumor cells, on the other hand, appeared to be round and shrunken with some dead cells when the RF is turned on.
Conclusions
We developed a wirelessly activated and soft drug delivery device. The prototype was designed, fabricated and demonstrated with drug release operation triggered by an external RF magnetic field. The electroactive IPMC cantilever was integrated with a planar LC receiver circuit consisting of a resonator and load loops. The cantilever serves as the actuator to control the opening gap of the release orifice using input power from the transmitter. The wireless coupling effects of the encapsulated LC receiver circuit were examined and analyzed, including a resonant frequency study in multiple media and position orientation at the transmitter circuit. The IPMC cantilever deflection and force profile were characterized at different RF voltages and repeated RF ON-OFF cycles. A proof-of-concept release of the drug cisplatin from the fabricated prototype shows the successful decrease of cell viability of HeLa cells with RF turned on. Future work will encompass the optimization of the device design and the further miniaturization of the device for lower loss and higher power transfer efficiency, as well as an in vivo study in animals.
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